SCHEMBL4614130

SCHEMBL4614130

CCCCOc1cc(C=CS(=O)(=O)OC(N)=O)n(Cc2ccc(Cl)cc2Cl)n1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PPARG P37231 18/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4614129 1.00 PPARG (0.53) PPARG
SCHEMBL4613183 0.89 PPARG (0.46) PPARG
SCHEMBL4613186 0.89 PPARG (0.46) PPARG
SCHEMBL3211081 0.87 PPARG (0.53) PPARG
SCHEMBL3211063 0.87 PPARG (0.53) PPARG
SCHEMBL4616873 0.86 PPARG (0.60) PPARG
SCHEMBL4616876 0.86 PPARG (0.60) PPARG
SCHEMBL3216911 0.84 PPARG (0.59) PPARG
SCHEMBL3216901 0.84 PPARG (0.59) PPARG
SCHEMBL4613029 0.83 PPARG (0.50) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed